NLIGHT INC (LASR)

US65487K1007 - Common Stock

10.75  +0.35 (+3.37%)

After market: 10.75 0 (0%)

Fundamental Rating

3

Overall LASR gets a fundamental rating of 3 out of 10. We evaluated LASR against 126 industry peers in the Electronic Equipment, Instruments & Components industry. No worries on liquidiy or solvency for LASR as it has an excellent financial health rating, but there are worries on the profitability. LASR has a expensive valuation and it also scores bad on growth.



Quickly go to:

1

1. Profitability

1.1 Basic Checks

LASR had negative earnings in the past year.
In the past year LASR had a positive cash flow from operations.
In the past 5 years LASR always reported negative net income.
The reported operating cash flow has been mixed in the past 5 years: LASR reported negative operating cash flow in multiple years.

1.2 Ratios

With a Return On Assets value of -16.84%, LASR is not doing good in the industry: 70.25% of the companies in the same industry are doing better.
LASR has a worse Return On Equity (-20.86%) than 66.94% of its industry peers.
Industry RankSector Rank
ROA -16.84%
ROE -20.86%
ROIC N/A
ROA(3y)-12.71%
ROA(5y)-10.13%
ROE(3y)-15.46%
ROE(5y)-12.37%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 20.53%, LASR is doing worse than 66.12% of the companies in the same industry.
LASR's Gross Margin has declined in the last couple of years.
LASR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 20.53%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.25%
GM growth 5Y-8.9%

More info and screens

8

2. Health

2.1 Basic Checks

LASR does not have a ROIC to compare to the WACC, probably because it is not profitable.
LASR has more shares outstanding than it did 1 year ago.
LASR has more shares outstanding than it did 5 years ago.
LASR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

LASR has an Altman-Z score of 4.95. This indicates that LASR is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 4.95, LASR is in the better half of the industry, outperforming 71.07% of the companies in the same industry.
There is no outstanding debt for LASR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 4.95
ROIC/WACCN/A
WACC10.31%

2.3 Liquidity

A Current Ratio of 5.83 indicates that LASR has no problem at all paying its short term obligations.
The Current ratio of LASR (5.83) is better than 86.78% of its industry peers.
LASR has a Quick Ratio of 4.48. This indicates that LASR is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of LASR (4.48) is better than 83.47% of its industry peers.
Industry RankSector Rank
Current Ratio 5.83
Quick Ratio 4.48

More info and screens

3

3. Growth

3.1 Past

LASR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -11.63%.
Looking at the last year, LASR shows a decrease in Revenue. The Revenue has decreased by -5.42% in the last year.
Measured over the past years, LASR shows a small growth in Revenue. The Revenue has been growing by 1.86% on average per year.
EPS 1Y (TTM)-11.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%20%
Revenue 1Y (TTM)-5.42%
Revenue growth 3Y-1.97%
Revenue growth 5Y1.86%
Sales Q2Q%10.85%

3.2 Future

LASR is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 0.50% yearly.
Based on estimates for the next years, LASR will show a small growth in Revenue. The Revenue will grow by 7.12% on average per year.
EPS Next Y-70.34%
EPS Next 2Y-20%
EPS Next 3Y0.5%
EPS Next 5YN/A
Revenue Next Year-1.45%
Revenue Next 2Y4.14%
Revenue Next 3Y7.12%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

LASR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for LASR. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-20%
EPS Next 3Y0.5%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for LASR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NLIGHT INC

NASDAQ:LASR (1/3/2025, 8:00:02 PM)

After market: 10.75 0 (0%)

10.75

+0.35 (+3.37%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)11-07 2024-11-07/amc
Earnings (Next)02-20 2025-02-20/amc
Inst Owners85.05%
Inst Owner Change-2.81%
Ins Owners4.49%
Ins Owner Change-0.28%
Market Cap520.62M
Analysts80
Price Target16.52 (53.67%)
Short Float %2.26%
Short Ratio2.48
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.34%
Min EPS beat(2)4.93%
Max EPS beat(2)23.75%
EPS beat(4)4
Avg EPS beat(4)12.01%
Min EPS beat(4)4.93%
Max EPS beat(4)23.75%
EPS beat(8)6
Avg EPS beat(8)10.3%
EPS beat(12)8
Avg EPS beat(12)-0.81%
EPS beat(16)12
Avg EPS beat(16)10.26%
Revenue beat(2)1
Avg Revenue beat(2)0.16%
Min Revenue beat(2)-0.43%
Max Revenue beat(2)0.76%
Revenue beat(4)2
Avg Revenue beat(4)1.24%
Min Revenue beat(4)-1.39%
Max Revenue beat(4)6.01%
Revenue beat(8)3
Avg Revenue beat(8)0.38%
Revenue beat(12)3
Avg Revenue beat(12)-1.37%
Revenue beat(16)6
Avg Revenue beat(16)-0.69%
PT rev (1m)-0.31%
PT rev (3m)2.53%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-228.12%
EPS NY rev (1m)-0.89%
EPS NY rev (3m)-21.07%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-13.89%
Revenue NY rev (1m)-0.46%
Revenue NY rev (3m)-3.5%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.56
P/FCF N/A
P/OCF 269.89
P/B 2.21
P/tB 2.35
EV/EBITDA N/A
EPS(TTM)-0.48
EYN/A
EPS(NY)-0.42
Fwd EYN/A
FCF(TTM)-0.09
FCFYN/A
OCF(TTM)0.04
OCFY0.37%
SpS4.19
BVpS4.86
TBVpS4.58
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -16.84%
ROE -20.86%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 20.53%
FCFM N/A
ROA(3y)-12.71%
ROA(5y)-10.13%
ROE(3y)-15.46%
ROE(5y)-12.37%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.25%
GM growth 5Y-8.9%
F-Score5
Asset Turnover0.7
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 37.28%
Cap/Sales 3.08%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.83
Quick Ratio 4.48
Altman-Z 4.95
F-Score5
WACC10.31%
ROIC/WACCN/A
Cap/Depr(3y)104.94%
Cap/Depr(5y)127.05%
Cap/Sales(3y)6.5%
Cap/Sales(5y)7.63%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-11.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%20%
EPS Next Y-70.34%
EPS Next 2Y-20%
EPS Next 3Y0.5%
EPS Next 5YN/A
Revenue 1Y (TTM)-5.42%
Revenue growth 3Y-1.97%
Revenue growth 5Y1.86%
Sales Q2Q%10.85%
Revenue Next Year-1.45%
Revenue Next 2Y4.14%
Revenue Next 3Y7.12%
Revenue Next 5YN/A
EBIT growth 1Y-1.33%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year76.65%
EBIT Next 3Y27.5%
EBIT Next 5YN/A
FCF growth 1Y91.18%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y107.82%
OCF growth 3Y-8.19%
OCF growth 5Y24.75%